ERADICATION OF CRYPTOSPORIDIUM IN A CHILD UNDERGOING MAINTENANCE CHEMOTHERAPY FOR LEUKEMIA USING HIGH-DOSE AZITHROMYCIN THERAPY

Citation
Ts. Russell et al., ERADICATION OF CRYPTOSPORIDIUM IN A CHILD UNDERGOING MAINTENANCE CHEMOTHERAPY FOR LEUKEMIA USING HIGH-DOSE AZITHROMYCIN THERAPY, Journal of pediatric hematology/oncology, 20(1), 1998, pp. 83-85
Citations number
8
Categorie Soggetti
Oncology,Hematology,Pediatrics
ISSN journal
10774114
Volume
20
Issue
1
Year of publication
1998
Pages
83 - 85
Database
ISI
SICI code
1077-4114(1998)20:1<83:EOCIAC>2.0.ZU;2-V
Abstract
Purpose: To describe a case of severe diarrhea caused by Cryptosporidi um in a patient undergoing maintenance chemotherapy. Important aspects of disease caused by Cryptosporidium, including diagnosis and treatme nt, are also reviewed. Methods and Results: A 4-year-old boy with acut e lymphoblastic anemia in remission had a prolonged course of diarrhea and wasting. C parvum was identified in the gastrointestinal tract by biopsy and in the stool using modified acid fast staining. Improvemen t in the stool consistency was noted after 3 days of therapy with azit hromycin, and, after 14 days of therapy, Cryptosporidium oocysts could no longer be identified in the stool. Conclusions: C parvum should be considered in all immunocompromised patients with severe or prolonged diarrhea, especially if there is no blood or leukocytes in the stool. Because Cryptosporidium is not always tested for in a routine ova and parasite examination, the lab should be notified if it is in the diff erential diagnosis. Azithromycin therapy may prove beneficial in the t reatment of intestinal Cryptosporidium in immunocompromised individual s.